Last reviewed · How we verify
BAY2927088 coated tablet 10 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BAY2927088 coated tablet 10 mg (BAY2927088 coated tablet 10 mg) — Bayer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BAY2927088 coated tablet 10 mg TARGET | BAY2927088 coated tablet 10 mg | Bayer | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BAY2927088 coated tablet 10 mg CI watch — RSS
- BAY2927088 coated tablet 10 mg CI watch — Atom
- BAY2927088 coated tablet 10 mg CI watch — JSON
- BAY2927088 coated tablet 10 mg alone — RSS
Cite this brief
Drug Landscape (2026). BAY2927088 coated tablet 10 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/bay2927088-coated-tablet-10-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab